News

Roche's phase III IMmotion151 study of Tecentriq & Avastin to treat advanced/metastatic RCC meets co-primary endpoint

Aurobindo Pharma Q1 revenue up 16% YoY

Our Bureau, Mumbai

Thursday, August 6, 2026, 12:45 Hrs [IST]

Aurobindo Pharma Limited announced its consolidated financial results for the quarter ended June 30, 2026.

To access the full article, please log in or subscribe.

Pharma Services

Tenders & Projects

Tenders & Enquires Pharma Projects

Corporate

Company Profile Corporate Results Corporate X-ray Pharmabiz Studies of Top Companies

US FDA Update

US FDA: ANDA US FDA: Warnings US FDA: Approved NMEs US FDA: Approved NMEs US FDA: REFUSAL

Export & Import

Drug Export Procedures Drug Units With WHO GMP Certification Pharma Export Data Import Reg. Update

Pharma Laws & Documents

Notifications Pharma Regulations Patent Laws and Amendments Patent Scan Documents New Drug Approvals Notified Prices

Labs & Govt Bodies

Govt Recognised In-House R&D Units AICTE Boards & Committees List of Indian CROs List of CROs (International) Govt & approved labs of India List of State Drugs Controllers

chemspec2017

CPHI-Istanbul-2017-150x60-stat-V1

cphikorea_150x60_k

CPhI-SEA-2017-150x50-stat-v1

pharmalogisticssummit-150-60

cphi_japanBanner150x60_2017

Pharma Project Management 2017

+ Font Resize -

Back

To access the full article, please log in or subscribe.